A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects with Friedreich’s Ataxia (FORWARD-FA)
|Jul 16 2026
Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich’s Ataxia (PROVE-FA)
|Mar 19 2024
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants with Friedreich’s Ataxia Aged 2 to 15 Years Old (BRAVE)
|Mar 19 2024
A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
|Mar 19 2024
A Randomized, Parallel-Arm, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Friedreich Ataxia (MOVE-FA)